RMC-6236 + gemcitabine and nab-paclitaxel for pancreatic cancer (RMC-GI-102_C)

RMC-6236 + gemcitabine and nab-paclitaxel for pancreatic cancer (RMC-GI-102_C)

Es posible que algunos contenidos no estén disponibles en español.

Study Details

Full Title

[RMC-GI-102_C] Study of RMC-6236 in Combination with Gemcitabine and Nabpaclitaxel in Patients with Metastatic Pancreatic Ductal Adenocarcinoma? Subprotocol C

Principal Investigator

John
Strickler

Protocol Number

PRO00115670

NCT ID

NCT06445062

Phase

I/II

Enrollment Status

Open to Enrollment